Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine | Immunotherapy
IJMS | Free Full-Text | Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial - The Lancet Gastroenterology & Hepatology
Pharmacogenomics of etanercept, infliximab, adalimumab and methotrexate in rheumatoid arthritis. A structured review
Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study - ScienceDirect
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study
Adalimumab in the treatment of arthritis | Semantic Scholar
Construct of pOptiVEC-HC adalimumab, containing the sequence of... | Download Scientific Diagram
3 Adalimumab
Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study - Chanchlani -
Peptide Mapping LC-MS/MS Analysis Workflow for Adalimumab
A1) Crystal structure of Adalimumab heavy chain Fab fragment. (A2)... | Download Scientific Diagram
Influence of first-line anti-TNF therapy on the effectiveness of adalimumab in ulcerative colitis: long-term clinical practice data - ILAPHAR | Revista de la OFIL
Adalimumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Peptide Mapping LC-MS/MS Analysis Workflow for Adalimumab
Amino acid sequences of adalimumab variable heavy (VH) and light chain... | Download Scientific Diagram
Figure 5 from Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases | Semantic Scholar
_[Adalimumab_Biosimilar_3].png "JAN: Japanese Accepted Names for Pharmaceuticals")
JAN: Japanese Accepted Names for Pharmaceuticals
The amino acid sequences of abatacept, alefacept, etanercept, and H... | Download Scientific Diagram
The Role of Liquid Chromatography–Mass Spectrometry in the Characterization of Therapeutic Monoclonal Antibodies
Human Anti-TNF-alpha IgG4 antibody | InvivoGen
RCSB PDB - 6CR1: adalimumab EFab
Peptide Mapping LC-MS/MS Analysis Workflow for Adalimumab
Structural Biology of the TNF Antagonists Used in the Treatment of Rheumatoid Arthritis
Anti-TNF-α therapies: the next generation | Nature Reviews Drug Discovery
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Analysis of Monoclonal Antibodies in Human Serum as a Model for Clinical Monoclonal Gammopathy by Use of 21 Tesla FT-ICR Top-Down and Middle-Down MS/MS | SpringerLink
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders - Sinah Engel, Felix Luessi, Aneka Mueller, Rudolf E. Schopf, Frauke Zipp, Stefan Bittner, 2020
EP3009450A1 - Liquid formulation comprising adalimumab and an acetate buffer - Google Patents
_[Adalimumab_Biosimilar_1].png "JAN: Japanese Accepted Names for Pharmaceuticals")